Hennion & Walsh Asset Management’s Arcturus Therapeutics ARCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Sell |
79,835
-19,419
| -20% | -$253K | 0.04% | 486 |
|
|
2025
Q1 | $1.05M | Buy |
99,254
+17,197
| +21% | +$182K | 0.05% | 462 |
|
|
2024
Q4 | $1.39M | Buy |
82,057
+47,824
| +140% | +$812K | 0.06% | 388 |
|
|
2024
Q3 | $795K | Sell |
34,233
-427
| -1% | -$9.91K | 0.04% | 507 |
|
|
2024
Q2 | $844K | Buy |
34,660
+2,730
| +9% | +$66.5K | 0.04% | 468 |
|
|
2024
Q1 | $1.08M | Buy |
31,930
+778
| +2% | +$26.3K | 0.06% | 401 |
|
|
2023
Q4 | $982K | Sell |
31,152
-23,446
| -43% | -$739K | 0.06% | 410 |
|
|
2023
Q3 | $1.39M | Buy |
54,598
+8,627
| +19% | +$220K | 0.09% | 281 |
|
|
2023
Q2 | $1.32M | Sell |
45,971
-19,545
| -30% | -$560K | 0.08% | 313 |
|
|
2023
Q1 | $1.57M | Sell |
65,516
-1,919
| -3% | -$46K | 0.1% | 256 |
|
|
2022
Q4 | $1.14M | Buy |
67,435
+7,072
| +12% | +$120K | 0.07% | 316 |
|
|
2022
Q3 | $895K | Sell |
60,363
-1,398
| -2% | -$20.7K | 0.06% | 351 |
|
|
2022
Q2 | $972K | Buy |
61,761
+2,376
| +4% | +$37.4K | 0.06% | 316 |
|
|
2022
Q1 | $1.6M | Buy |
59,385
+11,215
| +23% | +$302K | 0.09% | 253 |
|
|
2021
Q4 | $1.78M | Buy |
48,170
+18,157
| +60% | +$672K | 0.09% | 252 |
|
|
2021
Q3 | $1.43M | Buy |
30,013
+10,276
| +52% | +$491K | 0.08% | 285 |
|
|
2021
Q2 | $668K | Buy |
+19,737
| New | +$668K | 0.04% | 456 |
|